FTC report reveals significant markups by top PBMs on specialty drugs, driving $7.3 billion in revenue and raising costs for ...
The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.
(Bloomberg) -- Units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged significantly more than the national average acquisition cost for dozens of specialty generic drugs, bringing ...
The U.S. Federal Trade Commission (FTC) has slammed pharmacy benefit managers (PBMs) owned by UnitedHealth ($UNH), CVS Health ...
FTC Chair Lina Khan has the big three pharmacy benefit managers in sight—UnitedHealth's OptumRx, Cigna's Express Scripts and CVS Caremark Rx. © 2024 Fortune Media ...
According to FTC’s latest report, units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged significantly ...
The Federal Trade Commission said the companies made $7.3 billion over five years from the inflated drug prices This article ...
The US Federal Trade Commission said it sued CVS Health Corp. and Cigna Group for failing to turn over documents requested by the antitrust and consumer protection agency about their role as drug ...
International: Shares of the health care giant slid Thursday after it released its first financial report since the brazen ...
Oscar Health's targets of a 20% revenue CAGR through 2027 and 5% operating margin imply operating income around $700m in 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback